News
As the JavaScript implementation of the popular LangChain framework ... The framework supports various network architectures, including feed-forward networks, recursive neural networks, and long short ...
In an effort to save costs and make its financial resources last longer, Recursion Pharmaceuticals (NASDAQ: RXRX) is slimming ...
Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...
Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.
2h
Boing Boing on MSNDemoscene effects recreated in JavascriptWhat better name for a website that recreates the 90s VGA demoscene in javascript than 90s VGA Demoscene? Created by and ...
Fireship on MSN6h
D3.js in 100 SecondsData-Driven Documents or D3 is a JavaScript library for drawing SVGs with data. President Donald Trump announced that he and British Prime Minister Kier Starmer have officially signed a trade ...
In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results